Introductory EA Program Syllabus – Google Docs

Introductory EA Program Syllabus - Google Docs Introductory EA Program Syllabus - Google Docs

CellChorus Appoints Andrew Last, PhD, to Board of Directors November 28, 2023

CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how cells perform and interact over time, announced the appointment of Andrew Last, PhD, to its board of directors.

Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development Summit November 28, 2023

Sagimet Biosciences Inc. will present preclinical data at the 7th Obesity and NASH Drug Development Summit on November 28, 2023, in Boston.

Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion November 28, 2023

Skye Bioscience, Inc. has treated the first patient in its Phase 2 clinical trial evaluating SBI-100 Ophthalmic Emulsion’s (“OE”) ability to lower intraocular pressure (“IOP”), safety and relevant biomarkers, in patients with primary open-angle glaucoma ("POAG") or ocular hypertension ("OHT").

Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release November 28, 2023

Anika Therapeutics, Inc. today announced that the first surgeries using the Integrity Implant System were successfully performed by Dr. Christopher Baker at the Florida Orthopaedic Institute in Tampa, FL.

Derm-Biome Pharmaceuticals Announces Collaboration with Massachusetts General Hospital in Skin Cancer Study November 28, 2023

Derm-Biome Pharmaceuticals Inc is excited to announce that it is collaborating with Dr. Anna Mandinova from the Department of Dermatology at Massachusetts General Hospital in a skin cancer study.

Leave a Comment Cancel reply

Sam Harris: The Self is an Illusion | Big Think

Sean Carroll’s Mindscape